Dr. LP Si Yan Chai Hospital. Background With the increasing use of imaging modalities, more and more clinically inconspicuous thyroid lesions are discovered.

Slides:



Advertisements
Similar presentations
Case 20 Thomas J. Giordano, M.D., Ph.D.. History A 54-year old man with a past medical history of goiter for approximately 4 years was followed by ultrasound.
Advertisements

Hong CM, Ahn BC, Jeong SY, Lee SW, Lee J
The Thyroid Incidentaloma
Adrenal Incidentaloma: Evidence Based Approach
APPROACH TO A CASE OF THYROID NODULE
Lateral neck dissection for papillary thyroid cancer
Management of Thyroid Incidentalomas Department of Surgery Ruttonjee & TSK Hospitals Dr YC Lui.
Clinical Significance of Preoperative 18F-FDG PET Non- Avidity in Papillary Thyroid Carcinoma Do Hoon Koo 1, Ho-Young Lee 2, Kyu Eun Lee 3,4, So Won Oh.
18F- FDG PET/CT in the Diagnosis of Tumor Thrombosis
Papillary Microcarcinoma of the Thyroid T.T. Law Queen Mary Hospital Joint Hospital Surgical Grand Round 16th January, 2010.
Is the BRAF V600E mutation useful as a predictor of preoperative risk in papillary thyroid cancer? The American Journal of Surgery.
Update in the Management of Thyroid Neoplasms University of Washington
Total Lesion Glycolysis by 18 F-FDG PET/CT a Reliable Predictor of Prognosis in Soft Tissue Sarcoma Ilkyu Han Musculoskeletal Tumor Center, Seoul National.
JHSGR 16 th April 2011 Dr Lee Man Kit Derek.  The value of PET in staging adenocarcinoma (e.g. colorectal cancer) is well established Tomoharu T. et.
Emad Raddaoui, MD, FCAP, FASC Associate Professor; Consultant Histopathology & Cytopathology.
Management of differentiated thyroid cancer Dr. Leung Tak Lun Canice North District Hospital.
Role of Neck Dissection for Differentiated Thyroid CA Joint Hospital Surgical Grand Round NDH Dr. Alex TSANG.
Joint Hospital Surgical Grand Round United Christian Hospital
Joint Hospital Surgical Grand Round 21 st July, 2012 RH.
Thyroid Stuff Cytopathology & Pathology Ryan Orosco Sept 2013.
Thyroid nodules and neoplasms EMAD RADDAOUI, MD, FCAP, FASC ASSOCIATE PROFESSOR; CONSULTANT HISTOPATHOLOGY & CYTOPATHOLOGY.
THYROID TREATMENT AND VITAMIN D UPDATE A CPMC Regional CME Event - An Integrated Approach Saturday October 27, 2012.
Update on 18 F-Fluorodeoxyglucose/Positron Emission Tomography and Positron Emission Tomography/ Computed Tomography Imaging of Squamous Head and Neck.
ד"ר חגי מזא"ה כירורגיה אנדוקרינית מבואות כירורגיה שנה ד'
Approach to a thyroid nodule
Integrated PET/CT in Differentiated Thyroid Cancer: Diagnostic Accuracy and Impact on Patient Management J Nucl Med 2006; 47:616–624 報告者 : 蘇惠怡.
Dual-time point 18F-FDG PET/CT scan: is it always working?
Approach to the Thyroid Nodule
Thyroid Nodules Hollis Moye Ray, MD SEAHEC Internal Medicine June 3, 2011.
About these slides SPEC – Short Presentation in Emerging Concepts Provided by the CAP as an aid to pathologists to facilitate discussion on the topic.
Functional Imaging with PET for Sarcoma Rodney Hicks, MD, FRACP Director, Centre for Molecular Imaging Guy Toner, MD, FRACP Director, Medical Oncology.
radio-iodinated metaiodobenzylguanidine (123I-MIBG)
Dan Spratt, MD Department of Radiation Oncology Neuroendocrine Prostate Cancer: FDG-PET and Targeted Molecular Imaging.
IMAGING OF THE THYROID Dr Jill Hunt Consultant Radiologist West Herts NHS Trust.
ASNR 2015 Psammomatous Melanotic Schwannoma of The Spine: A Rare Case Report S Bakan, Y Kayadibi, E Ure, M Asik, Z I Hasiloglu Istanbul University Cerrahpasa.
Incidentally find an adrenal tumor on health screening by FDG-PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.
1. Clinical Impression? Differentials?. Thyroid Carcinoma commonly manifests as a painless, palpable, solitary thyroid nodule The patient's age at presentation.
Thyroid disease By Dr Fahad.
Examination of Pathology Demonstration of Thyroid Nodules And the Post Thyroidectomy Neck.
Management of thyroid nodule.  Introduction.  Guidelines recommendation.  Thyroid nodule work up.  Medical therapy in thyroid nodule  Thyroid nodule.
Thyroid Uptake on FDG PET/CT: What the Radiologist Needs to Know
Nick Wegner 4/22/10 The Use of CT in Diagnosing Pulmonary Metastases in Osteosarcoma.
Monday Case of the Day A) The treatment was successful: The bremsstrahlung SPECT (Fig 2) indicates that 90 Y was deposited in the tumor. B) The treatment.
Sonographic Extranodular and Intranodular Microcalcifications NIDHI AGRAWAL, MD VALERIE PECK, MD DIVISION OF ENDOCRINOLOGY, DIABETES AND METABOLISM NEW.
Date of download: 6/1/2016 From: Cost-Effectiveness of Alternative Management Strategies for Patients with Solitary Pulmonary Nodules Ann Intern Med. 2003;138(9):
간담도 암에서의 PET 의 활용 핵의학과 홍일기. 18 F-FDG PET: Warburg effect.
Background: Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor with a complex growth pattern. Imaging plays a crucial role in diagnosis.
Figure 1: a 32-year-old woman presented with RT breast mass, MRI showed false positive diagnosis of cancer. Dynamic contrast enhanced MRI, axial subtraction.
CLINICAL ASPECT OF GRADING AND STAGING Hanggoro Tri Rinonce, MD, PhD Department of Anatomical Pathology Faculty of Medicine, Gadjah Mada University.
J Clin Endocrinol Metab, Sep 2006, 91(9):
EPIDEMIOLOGY of THYROID CANCER in Iran
Management of Thyroid Nodules Detected at US: Society of Radiologists in Ultrasound Consensus Conference Statement Radiology 2005; 237: Presented.
Hua G, Hier M, Forest VI, Mlynarek A, Payne R.
Thyroid Nodule Case Studies
Follicular variant of papillary thyroid carcinoma
The utility of the Bethesda category and its association with BRAF mutation in the prediction of papillary thyroid cancer stage Augustas Beiša1, Mindaugas.
Managing Incidental Thyroid Nodules Detected on Imaging: White Paper of the ACR Incidental Thyroid Findings Committee  Jenny K. Hoang, MBBS, Jill E. Langer,
Molecular Markers in Thyroid Disease Yeah or Meh?
A diagnostic challenge: an incidental lung nodule in a 48-year-old nonsmoker Blake Christianson1, Smeet Patel MD1, Supriya Gupta MD1, Shikhar Vyas MD2,
Whole Body 18F-FDG PET/CT Imaging Staging of Malignant Melanoma:
Clinical Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Differentiation of Malignant Mesothelioma from Asbestos-Related.
VALUES OF ELASTOGRAPHY IN DIAGNOSIS OF THYROID CANCER
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Cheng-Chiao Huang, MD, MSc
Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease  Geoffrey M. Graeber, MD*, Naresh.
Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?  Kemp H Kernstine, MD, PhD, Kelley A McLaughlin,
Dr. Victoria Lai Department of Surgery, PYNEH
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer  Catherine A.B Saunders, Julian.
(A and B) Representative peaks using AKT primary antibody in normal lung and emphysema and tumour and matched normal lung, respectively. (A and B) Representative.
Category of no evidence of DTD in a 28-year-old woman.
Presentation transcript:

Dr. LP Si Yan Chai Hospital

Background With the increasing use of imaging modalities, more and more clinically inconspicuous thyroid lesions are discovered These are termed as thyroid incidentalomas Also include asymptomatic thyroid lesions identified during non-thyroid neck surgery, eg. parathyroidecotmy, carotid endarterectomy

Prevalence USG: 67% CT / MRI: 16% Carotid duplex: 9.4% FDG -PET: 2-3% Increasing use of FDG-PET Thyroid carcinomas detected by FDG-PET is more aggressive than those detected by other imaging modalities

FDG-PET Fluorodeoxyglucose positron emission tomography Mostly commonly used for Disease staging for patients with known malignancy Malignancy screening in healthy individuals

Increase FDG uptake in metabolically active tissue, e.g. malignancy, infection, inflammation, etc Normal thyroid gland not shown up

FDG-PET detected thyroid incidentalomas Unsuspected, asymptomatic thyroid lesions discovered on FDG-PET Prevalence % Increasing incidence but no increase in disease specific mortality Risk of malignancy 14-74% higher than incidental thyroid nodules found by USG, CT, or MRI

Is the thyroid incidentaloma on FDG-PET benign or malignant?

Pattern of uptake Focal Increase i n radioactivity concentration compared to that of the thyroid parenchyma Clearly delineated from the surrounding thyroid gl and Diffuse Ev en distribution of FDG in the entire thyroid gland Radioactivity concentration is higher than th at of the surrounding soft tissue

Focal uptake

Diffuse uptake

Focal uptake of thyroid lesions on PET also known as PETomas PET-associated incidental neoplasms (PAINs) PET de tected thyroid incidentalomas (PETI) Associated with an increased risk of malignancy than diffuse uptake

20 out of 27 patients who underwent operation proved to have thyroid malignancy (74%) Nishimori H et al. Incidental thyroid “PETomas”: clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake. Can J Surg Vol. 54, No.2, April 2011

SUV Standardized uptake value Elevated in metabolically active tissue Controversies about the use of SUV as an adjunct to differentiate between benign or malignant No cut off value

Katz SC et al. PET-Associated Incidental Neoplasms of the Thyroid. J Am Coll Surg (2008)

SUV correlates with the size of the thyroid incidentaloma in focal uptake r = 0.64, p < 0.05 Nilsson IL et al. Thyroid Incidentaloma Detected by Flurordeoxyglucose Positron Emission Tomography/Computed Tomography: Practical Management Algorithm. World J Surg (2011) 35:

Risk factors of malignancy Clinically apparent thyroid nodules are associated with 5% malignant rate Are et al. showed that risk of malignancy in the presence and absence of palpable thyroid nodule is 24% and 6.3% respectively (p = 0.01)

Focal FDG uptake and unilateral uptake are associated with higher malignancy rate Are C et al. FDG-PET Detected Thyroid Incidentalomas: Need for Further Investigation? Annals of Surgical Oncology (2006) 14(1):

FDG-PET detected incidental thyroid carcinomas Most are papillary thyroid carcinoma (PTC) Poor prognostic variants are more common Tall-cell variant papillary thyroid carcinoma (TCVPTC) Poorly differentiated thyroid carcinoma As high as 50% Extra-thyroidal extension is also more common Higher treatment failure rate Higher local, regional and distant recurrences Higher disease-specific mortality

TCVPTC More aggressive with a worse prognosis when compared to classical PTC (cPTC) High rate of extra-thyroidal extension Up to 90% in one series Commonly smaller than cPTC FNAC is warranted regardless of the size if the lesion is suspicious

Management Most of the patients already have a primary malignancy → the whole plan of management should depend on the overall prognosis and life expectancy USG thyroid is necessary for all patient No evident nodule → follow up Nodule ≥ 1cm or < 1cm with suspicious features → FNAC

Suspicious sonographic features Marked hypoechogenicity Taller than wide Irregular shape Ill-defined margin Punctate calcification Increase in vascularity

FNAC (Bethesda System) Nondiagnostic Benign Atypia of undetermined significance (AUS) Suspicious for follicular neoplasm / follicular neoplasm Suspicious for malignancy Malignant

FNAC resultsAction Non-diagnostic / AUSRepeat FNAC BenignFollow up Suspicious for follicular neoplasm / follicular neoplasm / suspicious for malignancy / malignant Operation

Conclusion FDG-PET detected thyroid incidentalomas harbour a significant risk of malignancy Thyroid carcinomas detected on FDG-PET are more aggressive and demonstrate poorer prognosis They should be investigated by USG +/- FNAC Definitive management plan depends on the overall prognosis and life expectancy of the patients

References American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer (2009) Jin J et al. Thyroid incidentaloma. Best Practice & Research Clinical Endocrinology & Metabolism 26 (2012) Nilsson IL et al. Thyroid Incidentaloma Detected by Flurordeoxyglucose Positron Emission Tomography/Computed Tomography: Practical Management Algorithm. World J Surg (2011) 35: Ho TY et al. Prevalence and significance of thyroid uptake detected by 18 F-FDG PET. Endocrine (2011) 40: Bertagna F et al. F18-PDF_PET/CT thyroid incidentalomas and their benign of malignant nature: a critical and debated issue. Ann Nucl Med (2011) 25: Nishimori H et al. Incidental thyroid “PETomas”: clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake. Can J Surg Vol. 54, No.2, April 2011 Law TT et al. Incidental Thyroid Carcinoma by FDG-PET/CT: A Study of Clinicopathological Characteristics. Ann Surg Oncol (2011) 18:

Jin J et al. Incidental thyroid nodule: patterns of diagnosis and rate of malignancy. The American Journal of Surgery (2009) 197, Kang BJ et al. Incidental thyroid uptake on F-18 FDG PET/CT: correlation with ultrasonography and pathology. Ann Nucl Med (2009) 23: Gough J et al. Thyroid Incidentaloma: An Evidence-based Assessment of Management Strategy. World J Surg (2008) 32: Katz SC et al. PET-Associated Incidental Neoplasms of the Thyroid. J Am Coll Surg (2008) Are C et al. Histological Aggressiveness of Fluorodeoxyglucose Positron-Emission Tomogram (FDG-PET)-Detected Incidental Thyroid Carcinomas. Annals of Surgical Oncology (2007) 14(11): Are C et al. FDG-PET Detected Thyroid Incidentalomas: Need for Further Investigation? Annals of Surgical Oncology (2006) 14(1):